Spring Works shares rise on raised price target to $66
TD Cowen analysts increased their price target for Spring Works Therapeutics (NASDAQ:SWTX) shares to $66.00 from $63.00, while maintaining a "Buy" rating on the stock. The company's shares, currently ...
Smurfit Westrock Shares Drop 6% After 4Q Earnings Miss
Smurfit Westrock shares were down 6% to $50.19 after the company reported fourth-quarter earnings that missed analysts' expectations.
ET Now on MSN5h
Promoters hike stake in THIS BSE Smallcap pharma company; share price below Rs 50
Sigachi Industries is a constituent of BSE Smallcap index. It is engaged in the manufacturing of Microcrystalline Cellulose ...
SpringWorks Therapeutics price target raised to $66 from $63 at TD Cowen
TD Cowen analyst Yaron Werber raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $66 from $63 and keeps a Buy rating on the ...
Xilio Therapeutics Shares Surge Premarket on AbbVie Deal
Xilio Therapeutics shares took flight in premarket trading Wednesday after the clinical-stage biotechnology company formed a potentially lucrative collaboration with AbbVie that includes an equity ...